(Press-News.org) New Rochelle, NY, February 21, 2013—By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease. New classes of drugs called antisense oligonucleotides are being designed to achieve this. Innovative work to develop a modified antisense drug that can be administered intravenously and achieve the desired therapeutic effect is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Nucleic Acid Therapeutics website.
Andrew Leger and coauthors from Genzyme, a Sanofi Company (Framingham, MA) added a peptide to an oligonucleotide strand designed to bind to and inactivate the mutated RNA region associated with myotonic dystrophy type 1 (DM1). The disease can affect function of the heart, central nervous system, and gastrointestinal tract, and a characteristic symptom is myotonia, in which muscles are slow to relax following contraction.
In the article "Systemic Delivery of Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy," the authors describe how the peptide is intended to enable systemic delivery of the drug, protecting it from being damaged or destroyed in the body before it can reach its target, the muscles. They report that intravenous introduction of the drug in a mouse model of DM1 led to good biodistribution of the drug, evidence that the problems previously caused by RNA toxicity were corrected, and complete elimination of myotonia in the treated mice.
"One of the greatest challenges to the therapeutic use of nucleic acids is effective and safe delivery," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "The work of Leger and his colleagues demonstrates a potentially powerful way to meet that challenge for many diseases."
INFORMATION:
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the Official Journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Metabolic Syndrome and Related Disorders, Population Health Management, Diabetes Technology & Therapeutics, and Journal of Women's Health. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot Street, New Rochelle, NY 10801-5215 www.liebertpub.com
Phone (914) 740-2100 (800) M-LIEBERT Fax (914) 740-2101
Drug delivery strategy eliminates myotonia symptoms in mice with myotonic dystrophy
2013-02-22
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Greater representation of elderly patients in Phase III trials are needed
2013-02-22
DENVER – The median age of patients diagnosed with advanced non–small-cell lung cancer (NSCLC) has steadily increased over the recent years and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials. A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, investigated the degree to which exclusion or underrepresentation of elderly occurs in practice-changing clinical trials in advanced NSCLC. Researchers conclude that greater representation ...
Local therapy followed by treatment with EGFR TKI is well tolerated
2013-02-22
DENVER – Local therapy is not commonly utilized in metastatic lung cancer. Researchers at Memorial Sloan-Kettering Cancer Center investigated the efficacy of local therapy with continued EGFR TKI therapy specifically in patients with acquired resistance to EGFR TKIs. A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, found that EGFR- mutant lung cancers with acquired resistance to EGFR TKI therapy are amenable to local therapy to treat oligometastatic disease when used in ...
UCSB anthropologist studies cattle ranchers in Brazilian Amazon
2013-02-22
(Santa Barbara, Calif.) –– For over a century, the rubber tappers of Acre, Brazil collected the valuable sap of the rubber trees from the forests of the western Amazon. As the demand for natural rubber declined, however, the Brazilian government sought to stimulate the economy in the 1970's by encouraging southern ranchers to bring their cattle to the isolated state and convert the forests to pastureland.
During the dramatic land conflicts that ensued, rubber tappers captured international media attention by arguing that their harvesting of rubber and other products from ...
Vibrant mix of marine life found at extreme ocean depths, Scripps analysis reveals
2013-02-22
The first scientific examinations of data recorded during a record-setting expedition have yielded new insights about the diversity of creatures that live and thrive in the cold, dark, and highly pressurized habitats of the world's deepest points and their vastly unexplored ecosystems.
Natalya Gallo of Scripps Institution of Oceanography at UC San Diego will present preliminary findings from the DEEPSEA CHALLENGE expedition, a project led by James Cameron in collaboration with Scripps, and supported by National Geographic and Rolex, on Feb. 22 (GS09: Community Ecology ...
February highlights from Ecological Society of America publications
2013-02-22
Weighing the costs and benefits of plastic vegetable greenhouses
The economic benefits of intensive vegetable cultivation inside plastic greenhouses, particularly for small-holders, have driven a rapid mushrooming of long plastic tents in farmlands worldwide – but particularly in China, where they cover 3.3 million hectares and produce approximately US $60 million in produce (2008 figures). The method conserves water, binds up carbon, shrinks land use, protects against soil erosion and exhaustion, and mitigates problematic dust storms. But this change from conventional ...
Flu breakthrough: New drug developed to combat flu pandemic
2013-02-22
The new drug has been proven to be effective in preventing the spread of different strains of influenza in laboratory models – including resistant strains of the virus.
The breakthrough is the result of a global collaboration between scientists from CSIRO, the University of British Columbia and the University of Bath.
In order to infect cells, flu viruses bind onto sugars on the cell surface. To be able to spread they need to remove these sugars. The new drug works by preventing the virus from removing sugars and blocking the virus from infecting more cells. It is hoped ...
Pulmonary fibrosis: Between a ROCK and a hard place
2013-02-22
Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure. Cells known as myofibroblasts normally secrete materials that are required for wound healing; once the wound has closed, the cells disappear. In pulmonary fibrosis, the myofibroblasts stick around, continuing to secrete wound healing factors that cause fibrosis in the lungs. In this issue of the Journal of Clinical Investigation, ...
JCI early table of contents for Feb. 22, 2013
2013-02-22
How to mend a broken heart: advances in parthenogenic stem cells
Parthenogenesis is a form of asexual reproduction during which unfertilized eggs begin to develop as if they had been fertilized. It occurs naturally in many plants and a few invertebrate (some bees, scorpions, parasitic wasps) and vertebrate animals (some fish, reptiles, and amphibians), but does not occur naturally in mammals. In 2007, researchers were able to chemically induce human egg cells to undergo parthenogenesis. The resulting parthenogenote has properties similar to an embryo, but cannot develop ...
How to mend a broken heart: Advances in parthenogenic stem cells
2013-02-22
Parthenogenesis is a form of asexual reproduction during which unfertilized eggs begin to develop as if they had been fertilized. It occurs naturally in many plants and a few invertebrate (some bees, scorpions, parasitic wasps) and vertebrate animals (some fish, reptiles, and amphibians), but does not occur naturally in mammals. In 2007, researchers were able to chemically induce human egg cells to undergo parthenogenesis. The resulting parthenogenote has properties similar to an embryo, but cannot develop further. In this issue of the Journal of Clinical Investigation, ...
Parents talking about their own drug use to children could be detrimental
2013-02-22
Washington, DC (February 19, 2013) – Parents know that one day they will have to talk to their children about drug use. The hardest part is to decide whether or not talking about ones own drug use will be useful in communicating an antidrug message. Recent research, published in the journal Human Communication Research, found that children whose parents did not disclose drug use, but delivered a strong antidrug message, were more likely to exhibit antidrug attitudes.
Jennifer A. Kam, University of Illinois at Urbana-Champaign and Ashley V. Middleton, MSO Health Information ...